Tag Archives: health

Jim Greenwood asks: How prepared are we for avian flu?

Jim Greenwood

As a serious avian influenza outbreak continues to wreak havoc on poultry farms across the U.S., one question that is beginning to draw attention from lawmakers and others centers on our ability to respond should the virus begin to infect humans. BIO President and CEO Jim Greenwood explored that issue in an op-ed yesterday at The Hill: The prospect of HPAI [Highly Pathogenic Avian Influenza] spreading to humans recently drew the attention of bipartisan leaders Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

A Glimpse into a New Era: Genetically Modified Animals


Science fiction and pop culture, such as the Jurassic Park franchise, narrate an unrealistic view of genetically modified animals. However, the use of genetically modified animals can improve livestock farming practices, save endangered species, and can even lead to cures for human diseases. In Kevin Loria’s entertaining and informative blog post, The age of genetically engineered animals has arrived, Loria speaks to the benefits of genetically engineered animals with real-life examples, discusses bioethics, and highlights the Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?


In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Scientific American WorldView Super Session and the Future of Innovation


The final Super Session of the 2015 BIO International Convention today featured a panel of international luminaries who offered their perspective on the future of innovation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, the panelists provided a fresh perspectives on international life science development and the ways disruptive technologies are changing how we do business and experience the world around us. On the panel: Lee Hood, President of Institute Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,